5.62
Nutriband Inc Aktie (NTRB) Neueste Nachrichten
Nutriband (NASDAQ: NTRB) Strengthens Pharma Footprint Through Key Alliances - The Globe and Mail
Nutriband Expands Market Presence Through Strategic Health Industry Partnerships - citybuzz -
Nutriband (NASDAQ: NTRB) Pioneers Innovative Approach to Opioid Crisis with Game-Changing Transdermal Patch - The Globe and Mail
Nutriband Develops Innovative Abuse-Deterrent Fentanyl Patch Amid Opioid Crisis Regulatory Changes - citybuzz -
Nutriband (NASDAQ: NTRB) Innovating Abuse-Deterrent Drug Delivery in a Shifting Opioid Landscape - The Globe and Mail
Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025 - ACCESS Newswire
(NTRB) Trading Report - news.stocktradersdaily.com
Nutriband Inc. to Ring NASDAQ Stock Market Opening Bell on December 3, 2021 - ACCESS Newswire
Nutriband (NASDAQ: NTRB) CEO Issues Shareholder Letter Highlighting Milestones, Commercialization Goals - Barchart.com
Examining Nutriband Inc (NTRB) more closely is necessary - uspostnews.com
A Tale of Resilience: Nutriband Inc Amid Stock Market Turbulence - investchronicle.com
Nutriband CEO Publishes Letter to Shareholders - GlobeNewswire
Nutriband (NASDAQ: NTRB) Leadership Team: Driving Innovation and Shaping the Future of Global Healthcare - The Globe and Mail
Nutriband (NTRB) Highlights Key Milestones and Future Goals Amid - GuruFocus
Nutriband Inc. (NASDAQ: NTRB) Solution To Fentanyl Abuse Could Translate To $200 Million In Peak Revenue - marketscreener.com
Nutriband CEO Publishes Letter to Shareholders | NTRB Stock News - GuruFocus
Nutriband projects strong sales for abuse-deterrent patches - Investing.com Australia
ForexTV | Small Business Resources - ForexTV
Nutriband Full Year 2025 Earnings: Misses Expectations - Yahoo Finance
Nutriband Inc reports results for the quarter ended January 31Earnings Summary - TradingView
NutriBand Inc. SEC 10-K Report - TradingView
Press Release Distribution & PR Platform - ACCESS Newswire
Should You Buy, Sell or Hold Amazon Stock Before Q1 Earnings? - The Globe and Mail
Why Nutriband (NASDAQ: NTRB) Is ‘One to Watch’ - The Globe and Mail
Big Oil Could Trim Buybacks After Price Rout - The Globe and Mail
Why Nutriband (NASDAQ: NTRB) Is ‘One To Watch’ - Barchart.com
Nutriband Inc. Provides Update on Seven-for-Six Forward Stock Split - ACCESS Newswire
Nutriband Inc. Initiates Plans to Offer Topical Lotion Contract Manufacturing Services - ACCESS Newswire
Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA Submission - ACCESS Newswire
Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st - ACCESS Newswire
Nutriband Inc. Announces $8.4M Private Placement - ACCESS Newswire
Is Disney Stock a Buy Now as Trump Tones Down Trade War Rhetoric? - The Globe and Mail
Nutriband (NASDAQ: NTRB): Building A Moat Around Abuse-Deterrent Drug Delivery - Barchart.com
(NTRB) Investment Report - news.stocktradersdaily.com
Nutriband (NASDAQ: NTRB): Building a Moat Around Abuse-Deterrent Drug Delivery - The Globe and Mail
Nutriband Strengthens Intellectual Property Portfolio for Abuse-Deterrent Drug Delivery - citybuzz -
Stocks in play: BioVaxys Technology Corp - The Globe and Mail
Nutriband (NASDAQ: NTRB) CEO Named EY Entrepreneur of the Year 2025 Finalist - The Globe and Mail
Nutriband (NASDAQ: NTRB) Is ‘One to Watch’ - The Globe and Mail
Nutriband (NASDAQ: NTRB) Is ‘One To Watch’ - Barchart.com
Nutriband Advances Opioid Safety with Innovative AVERSA Technology - citybuzz -
Nutriband (NTRB) Achieves Key Patent Approval in Macao for AVERS - GuruFocus
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology | NTRB Stock News - GuruFocus
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology - GlobeNewswire
Nutriband secures Macao patent for drug abuse deterrent tech By Investing.com - Investing.com South Africa
Nutriband Receives Patent for Abuse, Misuse Deterrent Transdermal Systems in Macao - marketscreener.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):